Okay, let's tackle this question about Nesidioblastosis. First, I need to remember what Nesidioblastosis is. It's a condition related to the pancreas, specifically the islet cells. From what I recall, it's associated with hypoglycemia because there's an overgrowth of beta cells, leading to excessive insulin secretion. The question asks which statement is NOT true about it.

The options aren't given, but the correct answer is supposed to be one of them. Let me think about common misconceptions or incorrect facts about Nesidioblastosis. For example, sometimes it's confused with insulinoma. Insulinomas are tumors that secrete insulin, but Nesidioblastosis is a diffuse condition, not a tumor. So if an option says it's a tumor, that's incorrect.

Another point: Nesidioblastosis can be congenital or acquired. Congenital cases are often in infants, causing hypoglycemia. Acquired might be in adults, sometimes associated with other conditions. If an option claims it's only congenital, that's wrong.

Diagnosis might involve imaging or a Whipple procedure to remove part of the pancreas. If an option mentions a specific test that's not used, like a CT scan (which is used, actually), that might be tricky. Wait, no—CT is used for insulinoma but maybe not always definitive for Nesidioblastosis. The gold standard is a 72-hour fast or imaging like endoscopic ultrasound.

Treatment usually involves surgery, like distal pancreatectomy. If an option says medical management is the first-line, that's incorrect. Also, hypoglycemia is the main symptom, so if an option says hyperglycemia, that's wrong.

Putting this together, the incorrect statement could be something like "It is a benign tumor of alpha cells" (which would be an insulinoma), or "It is treated with oral hypoglycemics" (which is not the case). The correct answer would be the option that states a falsehood about the condition.

**Core Concept** Nesidioblastosis is a rare pancreatic disorder characterized by diffuse hyperplasia of **beta cells** in the islets of Langerhans, leading to **inappropriate insulin secretion** and **refractory hypoglycemia**. It differs from insulinoma, which is a focal neoplasm. Diagnosis relies on exclusion of other causes of hypoglycemia and histopathological confirmation.

**Why the Correct Answer is Right** The correct statement is **not true** about Nesidioblastosis. A classic incorrect claim is that it is a **benign tumor** (e.g., insulinoma). Nesidioblastosis is a **diffuse, non-neoplastic proliferation** of beta cells, not a localized tumor. Its pathophysiology involves overactive beta-cell mass and dysregulated glucose sensing, leading to postprandial or fasting hypoglycemia.

**Why Each Wrong Option is Incorrect**
**Option A:** "It is associated with hyperglycemia." — Incorrect. Nesidioblastosis causes **hypoglycemia**, not hyperglycemia, due to excessive insulin.
**Option B:** "Diagnosis requires histopathological confirmation." — Correct. Histology showing diffuse beta-cell hyperplasia is

✓ Correct Answer: B. More common in adults than in children